Men with low risk prostate cancer must be offered option to 'watch and wait' instead of gruelling treatment Men with “low risk” prostate cancer should not be pushed into having treatment and should instead be offered a “watch and wait” approach, new guidance for the NHS suggests.
The recommendations mean thousands of men could be spared surgery and radiotherapy.
For the first time, the official advice from the National Institute for Health and Care Excellence (Nice) says there is no survival benefit to having treatment, in cases identified as low risk. The Daily Telegraph
See also:
The recommendations mean thousands of men could be spared surgery and radiotherapy.
For the first time, the official advice from the National Institute for Health and Care Excellence (Nice) says there is no survival benefit to having treatment, in cases identified as low risk. The Daily Telegraph
See also:
- Prostate cancer: diagnosis and management (guideline) NICE
- Prostate cancer (quality standard) NICE
- Men spared from chemotherapy as NHS adopts 'active surveillance' for prostate cancer patients The Daily Mail
No comments:
Post a Comment